Slide 1ASCO - Gastrointestinal Cancers Symposium Orlando (FL), 25-27 January 2008 First-line Irinotecan, Oxaliplatin and Infusional 5FU/LV (FOLFOXIRI) in combination with…
Anti-VEGF Therapy Goes Mainstream Lee M. Ellis, MD UT MD Anderson Cancer Center Houston, TX ASCO 2005 “Advancing the science of clinical oncology” What Have We Learned…